Bayer Corp FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Mar 20, 2025
  • Last warning letter 2017
Inspections 40 3 OAI
Recalls 1 0 Class I (0%)
Warning letters 2 Latest Nov 14, 2017
510(k) clearances 96 Latest Mar 3, 2003

Bayer Corp has 1 FDA recall, 40 inspections, 96 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to Bayer Corp, the most recent on Nov 14, 2017.

What these totals cover: FDA records filed under the name "Bayer Corp" and its spelling variant "Bayer". Records filed under related names are not included; see Related names.

Latest recall
Z-3147-2026 · Jul 31, 2026 · filed under Bayer Medical Care
Latest recall under this name
Z-1673-2014 · Class II · Apr 3, 2014
Latest inspection
Mar 20, 2025 · VAI
Latest 510(k)
Mar 3, 2003

Newer recall under related name Bayer Medical Care: Jul 31, 2026, Z-3147-2026.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances96Nov 22, 2026File dated Nov 18, 2026Current
Inspections40Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions2Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Bayer Corp's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Bayer Corp: FDA inspections per year

2017: 2 inspections (1 OAI), 1 warning letter, 0 recall records (0 Class I) 2018: 3 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 4 inspections (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 3 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510000
202420000
202330000
202210000
202110000
202010000
201941000
201830000
201721100

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Bayer Corp as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bayer Corp yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Bayer Corp FDA Warning Letters

2 warning letters from Aug 5, 2009 to Nov 14, 2017.

IssuedSubjectIssuing officeClose-out letter
Nov 14, 2017 · Record page
Aug 5, 2009 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

1 recall record on Apr 3, 2014.

NumberClassProductDate
Z-1673-2014Class IIMedrad Continuum MR Infusion system- non-wireless system The MEDRAD Continuum MR Infusion System…Apr 3, 2014

Recent FDA inspections

40 inspections from Mar 10, 2009 to Mar 20, 2025. Showing the 20 most recent. View all 40 inspections

DateSiteProductClassificationFEI
Mar 20, 2025Leverkusen, GermanyDrugsVoluntary Action Indicated (VAI)3002806462
Nov 14, 2024Bergkamen, GermanyDrugsVoluntary Action Indicated (VAI)3002808084
Jun 6, 2024Berlin, GermanyDrugsVoluntary Action Indicated (VAI)3002808086
Sep 15, 2023Turku, FinlandDrugsVoluntary Action Indicated (VAI)1000350927
Sep 7, 2023Leverkusen, GermanyDrugsVoluntary Action Indicated (VAI)3002806462
Jan 18, 2023Wuppertal, GermanyDrugsVoluntary Action Indicated (VAI)3003229486
May 13, 2022Leverkusen, GermanyDrugsNo Action Indicated (NAI)3002806462
Aug 27, 2021Berlin, GermanyDrugsVoluntary Action Indicated (VAI)3002808086
Jul 27, 2020Leverkusen, GermanyDrugsVoluntary Action Indicated (VAI)3002806462
Oct 10, 2019Bergkamen, GermanyDrugsVoluntary Action Indicated (VAI)3002808084
Sep 24, 2019Berlin, GermanyDrugsVoluntary Action Indicated (VAI)3002808086
Jul 11, 2019Wuppertal, GermanyDrugsVoluntary Action Indicated (VAI)3003229486
Mar 22, 2019Leverkusen, GermanyDrugsOfficial Action Indicated (OAI)3002806462
Jun 29, 2018Wuppertal, GermanyDrugsNo Action Indicated (NAI)3003229486
Jun 15, 2018Bergkamen, GermanyDrugsNo Action Indicated (NAI)3002808084
Jun 1, 2018Turku, FinlandDevicesNo Action Indicated (NAI)1000350927
Jan 24, 2017Berlin, GermanyDrugsNo Action Indicated (NAI)3002808086
Jan 20, 2017Leverkusen, GermanyDrugsOfficial Action Indicated (OAI)3002806462
Jun 3, 2016Leverkusen, GermanyDrugsNo Action Indicated (NAI)3002806462
Apr 15, 2016Turku, FinlandDrugsVoluntary Action Indicated (VAI)1000350927
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 2 compliance actions under Bayer Corp: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Nov 14, 2017.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

5 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3002806462Leverkusen, Germany10Mar 20, 2025
FEI 3002808084Bergkamen, Germany7Nov 14, 2024
FEI 3002808086Berlin, Germany9Jun 6, 2024
FEI 1000350927Turku, Finland6Sep 15, 2023
FEI 3003229486Wuppertal, Germany8Jan 18, 2023

Recent 510(k) clearances

96 510(k) clearances from Jun 16, 1989 to Mar 3, 2003. Showing the 20 most recent. View all 96 510(k) clearances

K-NumberDeviceDate
K024062ASCENSIA BREEZE BLOOD GLUCOSE METERMar 3, 2003
K023944BAYER DIAGNOSTICS CLINITEST PREGNANCY TESTFeb 11, 2003
K024017BAYER ADVIA CENTAUR HER-2/NEU ASSAYJan 30, 2003
K024234ASCENSIA GLUCOFACTS; ASCENSIA GLUCOFACTS PROFESSIONALJan 23, 2003
K022288COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEMDec 17, 2002
K023584ASCENSIA DEX 2 DIABETES CARE SYSTEMNov 20, 2002
K020828CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEMJul 24, 2002
K021428CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEMJul 5, 2002
K020806ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAYMar 27, 2002
K013568CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMDec 21, 2001
K012337BAYER ADVIA IMS SYSTEM; C-REACTIVE PROTEIN SYSTEMDec 6, 2001
K011963ADVIA 1650 GLUCOSE HEXOKINASE 11 ASSAYNov 20, 2001
K013272ACS: 180 AND ADVIA CENTAUR THEOPHYLLINE 2 ASSAYOct 25, 2001
K012777ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYSOct 22, 2001
K012340BAYER ADVIA SYSTEM; UNSATURATED IRON BINDING CAPACITY (UIBC)Oct 1, 2001
K012205GLUCOMETER DEX TEST SENSORSep 12, 2001
K010755BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGM ASSAYAug 20, 2001
K010668BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAYJul 5, 2001
K003412ADVIA CENTAUR RUBELLA IGG ASSAYApr 13, 2001
K010201BAYER ADVIA IMS SYSTEMMar 29, 2001

Bayer Corp and the FDA: common questions

Has Bayer Corp received an FDA warning letter?

Yes. FDA has issued 2 warning letters to Bayer Corp. The most recent is dated Nov 14, 2017.

Has Bayer Corp received an FDA Form 483?

FDA has not published a Form 483 for "Bayer Corp" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Bayer Corp?

The most recent FDA inspection on file ended Mar 20, 2025 at Leverkusen, Germany and was classified VAI. FDA has 40 inspections of Bayer Corp on file, 3 of them classified OAI (official action indicated).

Has Bayer Corp had an FDA recall?

Yes. Bayer Corp has 1 FDA recall on record. The most recent under this name started Apr 3, 2014. A newer recall, dated Jul 31, 2026, is filed under the related name Bayer Medical Care.

Need more than this page shows? Ask about Bayer Corp in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.